LOGIN
ID
PW
MemberShip
2025-11-18 03:09
All News
Policy
Company
Product
Opinion
InterView
°Ë»ö
Dailypharm Live Search
Close
Roche 2018 Annualreport
Roche 2018 Annualreport
2019-12-23
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2019-12-23
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
2019-11-15
Risk-Sharing Agreements in the EU: A Systematic Review
Risk-Sharing Agreements in the EU: A Systematic Review of Major Trends
2019-11-15
Managed Entry Agreements for
Managed Entry Agreements for Oncology Drugs
2019-11-15
OPINION
[Reporter¡¯s View] K-obesity drugs need to innovate
Reporter's view |
Choi, Da-eun
[Reporter¡¯s View] ¡®Selection & Focus¡¯ to foster K-Bios
Reporter's view |
Hwang, byoung woo
[Desk View] Unsettling relief from pharma tariff agreement
Desk's view |
Chon, Seung-Hyun
INTERVIEW
ADCs rise to become SOC in key solid tumors
Enhertu overtakes Kadcyla and becomes the standard of care¡¦ pushes into first-line
"GI Innovation challenges melanoma"
"...overcoming resistance to PD-1 antibodies" says Myoung Ho Jang, CEO of GI Innovation
"New landscape in DLBCL trt¡¦Columvi¡¤Polivy's bigger role"
Professor Gareth Gregory of Monash University in Australia
"Gilead-Kite will lead the trt landscape for DLBCL in KOR"
Diego Santoro, Head of the International Region for Kite Pharma
Dong-A ST launches Sterlara biosimilar Imuldosa in the US
Data
Roche 2018 Annualreport
Roche 2018 Annualreport
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
MOST READ
1
What's the outcome of the 2nd reimb attempt for 'Uplizna'?
2
KMA protests in front of the NA opposing INN prescribing
3
First batch of drugs gain reimb through AEN pilot project
4
Generic companies win 1st trial on unlisted Jardiance patent